Literature DB >> 2323773

Phenylketonuria mutation in Chinese haplotype 44 identical with haplotype 2 mutation in northern-European Caucasians.

T F Tsai1, K J Hsiao, T S Su.   

Abstract

DNA amplification with the polymerase chain reaction was employed to identify the phenylketonuria (PKU) mutation in Chinese PKU families. The amplified DNA was hybridized with oligonucleotides corresponding to the two most common mutant alleles, i.e., mutations associated with PKU haplotype 2 and 3 among Caucasians of northern-European ancestry. The results of analysis demonstrate that the mutation in Chinese haplotype 44 is a single-base substitution corresponding to the mutation associated with haplotype 2 in Caucasians, whereas the mutations of the phenylalanine hydroxylase gene in haplotypes 4, 7, 11 and 28 among Chinese do not correlate with either of the two mutations identified in northern-European Caucasians.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323773     DOI: 10.1007/bf00195810

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

2.  Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus.

Authors:  S L Woo
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

3.  Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria.

Authors:  A S Lidsky; F D Ledley; A G DiLella; S C Kwok; S P Daiger; K J Robson; S L Woo
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  Hybridization of genomic DNA to oligonucleotide probes in the presence of tetramethylammonium chloride.

Authors:  A G DiLella; S L Woo
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Multiple, independent restriction site polymorphisms in human DNA detected with a cDNA probe to argininosuccinate synthetase (AS).

Authors:  S P Daiger; N S Hoffman; R S Wildin; T S Su
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria.

Authors:  A G DiLella; J Marvit; A S Lidsky; F Güttler; S L Woo
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

8.  Phenylalanine hydroxylase gene haplotypes in Polynesians: evolutionary origins and absence of alleles associated with severe phenylketonuria.

Authors:  M Hertzberg; K Jahromi; V Ferguson; H H Dahl; J Mercer; K N Mickleson; R J Trent
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction.

Authors:  A G DiLella; W M Huang; S L Woo
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

View more
  10 in total

1.  Recurrent nonsense mutation in exon 7 of the phenylalanine hydroxylase gene.

Authors:  B Dworniczak; L Kalaydjieva; C Aulehla-Scholz; K Ullrich; I Kremensky; B Radeva; J Horst
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

2.  Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England.

Authors:  L A Tyfield; M J Osborn; J B Holton
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

3.  The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese population.

Authors:  Ying Liang; Miao-Zeng Huang; Cheng-Yi Cheng; Hung-Kun Chao; Victor Tramjay Fwu; Szu-Hui Chiang; Kwang-Jen Hsiao; Dau-Ming Niu; Tsung-Sheng Su
Journal:  J Hum Genet       Date:  2014-01-09       Impact factor: 3.172

Review 4.  The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.

Authors:  D S Konecki; U Lichter-Konecki
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

5.  The identification of two mis-sense mutations at the PAH gene locus in a Turkish patient with phenylketonuria.

Authors:  D S Konecki; M Schlotter; F K Trefz; U Lichter-Konecki
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

6.  Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France.

Authors:  S Lyonnet; D Melle; M de Braekeleer; R Laframboise; F Rey; S W John; M Berthelon; J Berthelot; H Journel; B Le Marec
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

7.  Identification of a missense phenylketonuria mutation at codon 408 in Chinese.

Authors:  C H Lin; K J Hsiao; T F Tsai; H K Chao; T S Su
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

8.  Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans.

Authors:  R C Eisensmith; A A Goltsov; C O'Neill; L A Tyfield; E I Schwartz; A I Kuzmin; S S Baranovskaya; G L Tsukerman; E Treacy; C R Scriver
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity.

Authors:  L R Desviat; B Pérez; M De Lucca; V Cornejo; B Schmidt; M Ugarte
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

10.  Multiple origins for phenylketonuria in Europe.

Authors:  R C Eisensmith; Y Okano; M Dasovich; T Wang; F Güttler; H Lou; P Guldberg; U Lichter-Konecki; D S Konecki; E Svensson
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.